These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6119432)

  • 21. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.
    van Rood JJ; van Leeuwen A; Goulmy E; Termijtelen A; Bradley BA; Brand A; Eernisse JG
    Transplant Proc; 1978 Mar; 10(1):47-51. PubMed ID: 24909
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal transfusion-associated graft-vs-host disease.
    Otsuka S; Kasuya S; Hirose M
    Aust N Z J Med; 1993 Jun; 23(3):308-9. PubMed ID: 8352710
    [No Abstract]   [Full Text] [Related]  

  • 23. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
    Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
    Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.
    Irlé C; Chapuis B; Jeannet M; Kaestli M; Montandon N; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2674-7. PubMed ID: 3547946
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mixed lymphocyte culture as a compatibility test for bone marrow transplantation].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1986 Jan; 98(2):44-9. PubMed ID: 2938340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of severe combined immunodeficiency with bone-marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor.
    Horowitz SD; Bach FH; Groshong T; Hong R; Yunis EJ
    Lancet; 1975 Sep; 2(7932):431-3. PubMed ID: 51239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Graft-versus-host disease in two newborns after repeated blood transfusions because of rhesus incompatibility (author's transl)].
    Böhm N; Kleine W; Enzel U
    Beitr Pathol; 1977 Aug; 160(4):381-400. PubMed ID: 20075
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation in leukaemia (review).
    Speck B
    Anticancer Res; 1981; 1(5):249-53. PubMed ID: 7049052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bone marrow graft: graft versus host reaction and rejection].
    Fischer A; Griscelli C
    Nephrologie; 1986; 7(3 Suppl):1-4. PubMed ID: 3534616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third party mixed-leukocyte culture test: a potential new method of histocompatibility testing.
    Park BH; Good RA
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1490-3. PubMed ID: 4113869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.
    Parkman R; Mosier D; Umansky I; Cochran W; Carpenter CB; Rosen FS
    N Engl J Med; 1974 Feb; 290(7):359-63. PubMed ID: 4149239
    [No Abstract]   [Full Text] [Related]  

  • 33. Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions.
    Graw RG; Buckner CD; Whang-Peng J; Leventhal BG; Krüger G; Berard C; Henderson ES
    Lancet; 1970 Aug; 2(7668):338-41. PubMed ID: 4194443
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent advances in transplantation of incompatible marrow in infants with combined immunodeficiency disease.
    Park BH; Biggar WD; Yunis EJ; Good RA
    Transplant Proc; 1973 Mar; 5(1):899-903. PubMed ID: 4144469
    [No Abstract]   [Full Text] [Related]  

  • 35. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.
    Vogelsang GB; Hess AD; Berkman AW; Tutschka PJ; Farmer ER; Converse PJ; Santos GW
    N Engl J Med; 1985 Sep; 313(11):645-50. PubMed ID: 3894963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of histocompatibility using cell-mediated lympholysis].
    Potmĕsilová I; Soucek J; Novák JT
    Vnitr Lek; 1980 Nov; 26(11):1072-8. PubMed ID: 6455007
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic reconstitution in severe combined immunodeficiency with HL-A-incompatible bone marrow graft: donor selection by mixed lymphocyte culture.
    Dupont B; Andersen V; Ernst P; Faber V; Good RA; Hansen GS; Henriksen K; Jensen K; Juhl F; Killmann SA; Koch C; Muller-Berat N; Park BH; Svejgaard A; Thomsen M; Wiik A
    Transplant Proc; 1973 Mar; 5(1):905-8. PubMed ID: 4144470
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.
    Gordon-Smith EC; Fairhead SM; Chipping PM; Hows J; James DC; Dodi A; Batchelor JR
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):835-7. PubMed ID: 6214294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
    Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
    Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitoring of graft versus host (GVH) reaction and host versus graft (HVG) reaction].
    Tanaka S; Orita K
    Nihon Rinsho; 1990 Sep; 48(9):2041-7. PubMed ID: 2232208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.